Nine (20.5%) of 44 patients in the fluvastatin group and Eleven (26.2%) of 42 patients in the placebo group had at least 1 MACE.

• 结果治疗组无主要不良心血管事件(MACE)的生存时间显著延长(P=0.；01)；治疗组有9例(20